Compounds > glutamic acid

glutamic acid and Lewy Body Disease

glutamic acid has been researched along with Lewy Body Disease in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (58.33)29.6817
2010's4 (33.33)24.3611
2020's1 (8.33)2.80

Authors

AuthorsStudies
Bell, BM; Giasson, BI; Gorion, KM; Lee, EB; Lloyd, GM; Paterno, G; Prokop, S; Quintin, S; Sorrentino, Z; Xia, Y1
Chen, J; Chen, X; Fang, Y; Hou, L; Huang, G; Liu, S; Luo, X; Mu, N; Ning, Y; Shen, Z; Shi, H; Tan, Y; Wu, R; Zhang, H; Zhang, Y; Zheng, D; Zhong, X1
Adame, A; Campioni, S; Gage, FH; Gerez, J; Jensen, PH; Mante, M; Masliah, E; Nuber, S; Overk, CR; Patrick, C; Picotti, P; Riek, R; Rockenstein, E; Trejo-Morales, M; Ubhi, K; Winkler, J; Winner, B1
Blurton-Jones, M; Caesar, J; Davis, J; Finogenov, G; Goldberg, NRS; Masliah, E; Park, A; Sedgh, S1
Blamire, AM; Hayes, L; He, J; O'Brien, JT; Su, L; Watson, R1
Freund, HJ; Klosterkoetter, J; Kuhn, J; Lenartz, D; Mai, JK; Schnell, T; Sturm, V1
Emre, M1
Aarsland, D; Alves, G; Ballard, C; Bostrom, F; Kossakowski, K; Leroi, I; Londos, E; Minthon, L; Pozo-Rodriguez, F; Walker, Z1
Gómez, P; Manzanares, J; Molina, JA; Oliva, JM; Ortiz, S; Pérez-Rial, S; Urigüen, L; Vargas, C; Villanueva, C1
Albasanz, JL; Dalfó, E; Ferrer, I; Martin, M2
Francis, PT; Perry, EK1

Reviews

1 review(s) available for glutamic acid and Lewy Body Disease

ArticleYear
Cholinergic and other neurotransmitter mechanisms in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies.
    Movement disorders : official journal of the Movement Disorder Society, 2007, Volume: 22 Suppl 17

    Topics: Acetylcholine; Atrophy; Cerebral Cortex; Cholinergic Fibers; Dementia; Glutamic Acid; Humans; Lewy Body Disease; Nerve Degeneration; Parkinson Disease; Receptors, Nicotinic; Serotonin; Synaptic Transmission

2007

Trials

2 trial(s) available for glutamic acid and Lewy Body Disease

ArticleYear
Cognitive functions in a patient with Parkinson-dementia syndrome undergoing deep brain stimulation.
    Archives of neurology, 2009, Volume: 66, Issue:6

    Topics: Acetylcholine; Aged; Arousal; Attention; Basal Nucleus of Meynert; Cholinergic Fibers; Cognition; Cognition Disorders; Deep Brain Stimulation; Double-Blind Method; Electrodes, Implanted; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Lewy Body Disease; Male; Neuropsychological Tests; Parkinsonian Disorders; Prospective Studies; Recovery of Function; Social Behavior; Subthalamic Nucleus; Treatment Outcome

2009
Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial.
    The Lancet. Neurology, 2009, Volume: 8, Issue:7

    Topics: Aged; Aged, 80 and over; Brain; Cognition; Cognition Disorders; Double-Blind Method; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Humans; Lewy Body Disease; Male; Memantine; Neuropsychological Tests; Outcome Assessment, Health Care; Parkinson Disease; Patient Selection; Placebo Effect; Placebos; Psychomotor Performance; Reaction Time; Treatment Outcome

2009

Other Studies

9 other study(ies) available for glutamic acid and Lewy Body Disease

ArticleYear
Cellular processing of α-synuclein fibrils results in distinct physiological C-terminal truncations with a major cleavage site at residue Glu 114.
    The Journal of biological chemistry, 2023, Volume: 299, Issue:7

    Topics: alpha-Synuclein; Animals; Autopsy; Glutamic Acid; Humans; Lewy Body Disease; Lysosomes; Mice; Mice, Transgenic; Multiple System Atrophy; Prions; Protease Inhibitors

2023
1H-proton magnetic resonance spectroscopy differentiates dementia with Lewy bodies from Alzheimer's disease.
    Journal of Alzheimer's disease : JAD, 2014, Volume: 40, Issue:4

    Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Aspartic Acid; Cerebral Cortex; Chi-Square Distribution; Female; Glutamic Acid; Humans; Lewy Body Disease; Linear Models; Magnetic Resonance Imaging; Male; Middle Aged; Proton Magnetic Resonance Spectroscopy; ROC Curve

2014
Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo.
    Brain : a journal of neurology, 2014, Volume: 137, Issue:Pt 5

    Topics: alpha-Synuclein; Alzheimer Disease; Animals; Brain; Disease Models, Animal; Gene Expression Regulation; Glutamic Acid; Humans; Lewy Body Disease; Lysine; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Nerve Degeneration; Nerve Tissue Proteins; Neurons; Synapses; Thy-1 Antigens

2014
Neural Stem Cells Rescue Cognitive and Motor Dysfunction in a Transgenic Model of Dementia with Lewy Bodies through a BDNF-Dependent Mechanism.
    Stem cell reports, 2015, Nov-10, Volume: 5, Issue:5

    Topics: alpha-Synuclein; Animals; Brain-Derived Neurotrophic Factor; Cells, Cultured; Cognition; Corpus Striatum; Dopamine; Glutamic Acid; Lewy Body Disease; Locomotion; Mice; Mice, Inbred C57BL; Neural Stem Cells

2015
Whole-brain patterns of (1)H-magnetic resonance spectroscopy imaging in Alzheimer's disease and dementia with Lewy bodies.
    Translational psychiatry, 2016, 08-30, Volume: 6, Issue:8

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Brain; Case-Control Studies; Choline; Creatine; Female; Glutamic Acid; Glutamine; Humans; Inositol; Lewy Body Disease; Magnetic Resonance Imaging; Male; Proton Magnetic Resonance Spectroscopy

2016
Memantine: a new hope for treatment of Lewy body-related dementias?
    The Lancet. Neurology, 2009, Volume: 8, Issue:7

    Topics: Aged; Brain; Brain Chemistry; Clinical Trials as Topic; Drug Interactions; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Lewy Body Disease; Memantine; Parkinson Disease; Placebo Effect; Synaptic Transmission; Treatment Outcome

2009
Neurotransmitter amino acid in cerebrospinal fluid of patients with dementia with Lewy bodies.
    Journal of neural transmission (Vienna, Austria : 1996), 2005, Volume: 112, Issue:4

    Topics: Age Factors; Age of Onset; Aged; Asparagine; Aspartic Acid; Body Mass Index; Brain; Cerebrospinal Fluid; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glycine; Humans; Lewy Body Disease; Male; Neuropsychological Tests; Neurotransmitter Agents

2005
Abnormal metabotropic glutamate receptor expression and signaling in the cerebral cortex in diffuse Lewy body disease is associated with irregular alpha-synuclein/phospholipase C (PLCbeta1) interactions.
    Brain pathology (Zurich, Switzerland), 2004, Volume: 14, Issue:4

    Topics: Aged; Aged, 80 and over; alpha-Synuclein; Cell Fractionation; Cell Membrane; Cerebral Cortex; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Female; Glutamic Acid; Guanosine Triphosphate; Humans; Immunoblotting; Immunohistochemistry; Immunoprecipitation; Lewy Body Disease; Male; Membrane Proteins; Microscopy, Confocal; Middle Aged; Nerve Tissue Proteins; Postmortem Changes; Proline; Propionates; Protein Binding; Quisqualic Acid; Radioligand Assay; Receptors, Glutamate; Signal Transduction; Synaptosomal-Associated Protein 25; Synucleins; Tritium; Type C Phospholipases

2004
Impaired metabotropic glutamate receptor/phospholipase C signaling pathway in the cerebral cortex in Alzheimer's disease and dementia with Lewy bodies correlates with stage of Alzheimer's-disease-related changes.
    Neurobiology of disease, 2005, Volume: 20, Issue:3

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Binding, Competitive; Disease Progression; Down-Regulation; Enzyme Activation; Female; Frontal Lobe; Glutamic Acid; Guanosine Triphosphate; Humans; Isoenzymes; Lewy Body Disease; Male; Middle Aged; Neurons; Phospholipase C beta; Radioligand Assay; Receptors, Metabotropic Glutamate; Signal Transduction; Type C Phospholipases

2005